Palbociclib (PD0332991)

SKU: orb1307454

特色

描述

Palbociclib is an orally bioavailable, potent inhibitor of CDK4 and CDK6 (IC50 11/16 nM) with anti-tumor activity. It is widely investigated in preclinical in vitro and in vivo studies for ER-positive, HER2-negative breast cancer and other cyclin D-driven malignancies.

研究领域

Cell Biology, Immunology & Inflammation

图片与验证

−

关键属性

−

CAS 号	571190-30-2
MW	447.53
纯度	>98%
分子式	C₂₄H₂₉N₇O₂
SMILES	O=C1N(C=2C(C(C)=C1C(C)=O)=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N2)C5CCCC5
靶点	Kinase
溶解性	Soluble in DMSO (up to 2 mg/ml with warming)

生物活性

−

靶点 IC50	MAPK:8000 nM\|DYRK1A:2000 nM\|CDK4:11 nM\|ICNI cells:8 µM\|CDK6:16 nM\|KB-C2 cells:22.573 µM\|CDK4-CyclinD3:9 nM\|CDK6-CyclinD2:16 nM\|CDK4-CyclinD1:11 nM
体内	METHODS: To detect antitumor activity in vivo, Palbociclib (12.5-150 mg/kg, sodium lactate buffer (50 mmol/L, pH 4.0)) was administered orally to immunodeficient mice harboring the tumors Colo-205 or MDA-MB-435 once daily for fourteen days. RESULTS: Palbociclib showed significant anti-tumor efficacy in multiple human tumor xenograft models. In Colo-205 tumors, PD 0332991 administered for 14 days produced rapid tumor regression. METHODS: To assay antitumor activity in vivo, Palbociclib (150 mg/kg, sodium lactate buffer (50 mM, pH = 4.0)) was administered once daily for two weeks by gavage to nu/nu BALB/c mice bearing esophageal squamous cell carcinoma (ESCC) tumors EC109 or KYSE150. RESULTS: Palbociclib effectively inhibited ESCC tumor growth and lung metastasis.
体外	METHODS: Malignant rhabdomyosarcoma cells G401, MP-MRT-AN (AN), KP-MRT-RY (RY), KP-MRT-NS (NS), and KP-MRT-YM (YM) were treated with Palbociclib (0-1 mM) for 24 h, and cell viability was assayed by WST. RESULTS: Palbociclib effectively inhibited AN, RY, G401 and NS cell lines in a concentration-dependent manner, with IC50s of 0.01 μM, 0.01 μM, 0.06 μM and 0.6 μM, respectively; on the contrary, the YM cell line was resistant to Palbociclib, with an IC50 >10 μM. METHODS: Human breast cancer cells MDA-MB-453 were treated with Palbociclib (0.02-10 μmol/L) for 24 h, and the cell cycle was examined by Flow Cytometry. RESULTS: Palbociclib caused G1 phase block.
细胞研究	Palbociclib (PD) is prepared in DMSO and stored ( 80°C), and then diluted with appropriate media before use. MRT cell lines, G401, MP-MRT-AN (AN), KP-MRT-RY (RY), KP-MRT-NS (NS), and KP-MRT-YM (YM) cell lines are seeded in normal growth medium into 96-well cell plates. After 24 h, the culture medium is replaced with culture medium containing Palbociclib (0.05 or 1 μM) or DMSO. Cells are cultured and treated in triplicate. Cell proliferation is determined 8 days after the treatment by WST-8 assay using a Cell Counting Kit-8.

储存与操作

−

储存	-20°C
有效期	12 months from date of receipt.
免责声明	For research use only

别名

−

PD-332991

相似产品

−

Palbociclib hydrochloride [orb1686464]
纯度：
99.89% (May vary between batches)
CAS 号：
571189-11-2
MW:
520.46
分子式：
C₂₄H₃₁Cl₂N₇O₂
可选规格： 100 mg, 250 mg, 1 g
Palbociclib Isethionate [orb1300947]
纯度：
99.85% (May vary between batches)
CAS 号：
827022-33-3
MW:
573.66
分子式：
C₂₄H₂₉N₇O₂·C₂H₆O₄S
可选规格： 5 mg, 10 mg, 1 ml x 10 mM (in DMSO)
Palbociclib monohydrochloride [orb1300948]
纯度：
>99.99% (May vary between batches)
CAS 号：
827022-32-2
MW:
483.99
分子式：
C₂₄H₂₉N₇O₂·HCl
可选规格： 5 mg, 2 mg, 10 mg
Palbociclib (PD0332991) Isethionate [orb1223927]
纯度：
>98% (HPLC)
CAS 号：
827022-33-3
MW:
573.66
分子式：
C₂₄H₂₉N₇O₂·C₂H₆O₄S
可选规格： 5 mg, 50 mg, 500 mg, 1 g, 10 mg, 100 mg, 200 mg
Palbociclib hydrochloride [orb1223928]
纯度：
>98% (HPLC)
CAS 号：
827022-32-2
MW:
483.9937
分子式：
C₂₄H₃₀ClN₇O₂
可选规格： 100 mg, 500 mg, 1 g, 5 mg, 10 mg, 50 mg, 200 mg

质量保证

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.

化合物标识

PubChem CID

5330286 ↗

关键属性

−

暂无计算属性。

实验方案信息

查看更多实验方案

纯度：	99.89% (May vary between batches)
CAS 号：	571189-11-2
MW:	520.46
分子式：	C₂₄H₃₁Cl₂N₇O₂

纯度：	99.85% (May vary between batches)
CAS 号：	827022-33-3
MW:	573.66
分子式：	C₂₄H₂₉N₇O₂·C₂H₆O₄S

纯度：	>99.99% (May vary between batches)
CAS 号：	827022-32-2
MW:	483.99
分子式：	C₂₄H₂₉N₇O₂·HCl

纯度：	>98% (HPLC)
CAS 号：	827022-33-3
MW:	573.66
分子式：	C₂₄H₂₉N₇O₂·C₂H₆O₄S

Palbociclib (PD0332991)

描述

研究领域

图片与验证

关键属性

生物活性

储存与操作

别名

相似产品

Palbociclib hydrochloride [orb1686464]

Palbociclib Isethionate [orb1300947]

Palbociclib monohydrochloride [orb1300948]